Vycor Medical Inc
Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive co… Read more
Market Cap & Net Worth: Vycor Medical Inc (VYCO)
Vycor Medical Inc (OTCQB:VYCO) has a market capitalization of $2.17 Million ($2.17 Million) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #36420 globally and #11850 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vycor Medical Inc's stock price $0.07 by its total outstanding shares 33372796 (33.37 Million).
Vycor Medical Inc Market Cap History: 2015 to 2025
Vycor Medical Inc's market capitalization history from 2015 to 2025. Data shows change from $28.86 Million to $2.17 Million (-27.75% CAGR).
Vycor Medical Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vycor Medical Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.06x
Vycor Medical Inc's market cap is 2.06 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $28.86 Million | $1.14 Million | -$2.08 Million | 25.35x | N/A |
| 2016 | $11.34 Million | $1.45 Million | -$1.65 Million | 7.81x | N/A |
| 2017 | $17.02 Million | $1.38 Million | -$1.48 Million | 12.29x | N/A |
| 2018 | $2.74 Million | $1.51 Million | -$1.38 Million | 1.81x | N/A |
| 2019 | $4.62 Million | $1.48 Million | -$796.20K | 3.11x | N/A |
| 2020 | $3.34 Million | $1.14 Million | -$822.48K | 2.92x | N/A |
| 2021 | $3.27 Million | $1.39 Million | -$435.66K | 2.35x | N/A |
| 2022 | $3.00 Million | $1.22 Million | -$404.92K | 2.46x | N/A |
| 2023 | $2.57 Million | $1.46 Million | -$69.69K | 1.76x | N/A |
| 2024 | $3.27 Million | $1.59 Million | -$107.20K | 2.06x | N/A |
Competitor Companies of VYCO by Market Capitalization
Companies near Vycor Medical Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Vycor Medical Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Vycor Medical Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Vycor Medical Inc's market cap moved from $28.86 Million to $ 2.17 Million, with a yearly change of -27.75%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $2.17 Million | -33.67% |
| 2024 | $3.27 Million | +27.27% |
| 2023 | $2.57 Million | -14.44% |
| 2022 | $3.00 Million | -8.16% |
| 2021 | $3.27 Million | -2.00% |
| 2020 | $3.34 Million | -27.69% |
| 2019 | $4.62 Million | +68.66% |
| 2018 | $2.74 Million | -83.92% |
| 2017 | $17.02 Million | +50.01% |
| 2016 | $11.34 Million | -60.70% |
| 2015 | $28.86 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Vycor Medical Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.17 Million USD |
| MoneyControl | $2.17 Million USD |
| MarketWatch | $2.17 Million USD |
| marketcap.company | $2.17 Million USD |
| Reuters | $2.17 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.